Concepedia

Publication | Closed Access

The Efficacy and Safety of SGLT2 Inhibitor in Diabetic Kidney Transplant Recipients

DOI

97

Citations

24

References

2022

Year

Jeong‐Hoon Lim, Soie Kwon, Yena Jeon, Young‐Hoon Kim, Hyunwook Kwon, Yon Su Kim, Hajeong Lee, Yong-Lim Kim, Chan‐Duck Kim, Jong Soo Lee,
Transplantation

Abstract

SGLT2i improved a composite of all-cause mortality, DCGF, or serum creatinine doubling in KTRs. SGLT2i can be used safely and have beneficial effects on preserving graft function in diabetic KTRs.

References

YearCitations

Page 1